A Study of Expiratory Pressure Modulation in Moderate to Severe COPD Patients - Phase 1b

Clinical trial NCT02585752 · TERMINATED

Trial details

NCT number: NCT02585752
Sponsor: ResMed
Status: TERMINATED
Phase: Not Applicable
Study type: INTERVENTIONAL

Chronic Obstructive Pulmonary Disease

Start date: 2015-10-01
Primary completion: 2017-09-30
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.